United Therapeutics Corporation
UTHR
$543.40-1.22%
End of day · as of Oct 13, 2026, 8:00 PM ET
Mkt cap
$23.41B
EV/Sales
6.87
P/E ratio
N/A
FY2025 Revenue
$3.18B
EPS (TTM)
$27.91
Gross Margin (FY2025)
87.92%
Profit Margin (FY2025)
41.94%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported UTHR revenue for 2025-12-31 was $3.18B. Net income was $1.33B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. UTHR currently screens at market cap $23.41B.
Use this UTHR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full UTHR income, balance, and cash tables.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached United Therapeutics Corporation (UTHR) revenue for Dec 31, 2025 was $3.18B. Net income was $1.33B. Statements: https://lician.com/financials/uthr
United Therapeutics Corporation (UTHR) market capitalization is $23.41B on the latest cached snapshot.
United Therapeutics Corporation (UTHR) cached previous close $550.10; day range $543.40 – $551.59; volume 503,759. Session quote: https://lician.com/quote/uthr
United Therapeutics Corporation (UTHR) latest cached earnings event is "UTHR earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings